CNS Drugs July 2023 PMID 37430151

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.

Maxwell Z Price, Richard L Price

Full text PDF Download social card

Mentions

Peak: 1 in Nov 2023

across 3 sources since Nov 2023

Extended reach

1,113,887

potential audience

Total likes

24,632

Video views

1,113,882

Mentions per month

Nov 2023 – Jul 2025

Where it's discussed

News6 articles
Bluesky2 posts
YouTube2 videos

AI synopsis

What people are saying

The overall discussions are characterized by brief reactions and sharing of resources, such as linking to videos and expressing personal usefulness, which suggests moderate interest but limited deep engagement or perceived impact. The tone varies from dismissive to mildly curious, with minimal detailed analysis or debate about the research findings.

AgreementNeither agree nor disagree

The discussions include one dismissive comment, but overall there is no clear consensus for or against the publication, leading to a neutral agreement score.

InterestModerate interest

Some comments show curiosity and mention finding the research useful, indicating moderate interest.

EngagementNeutral engagement

The comments are brief and primarily share links or quick reactions, reflecting low to moderate engagement.

ImpactNeutral impact

Most comments seem casual or personal, with little indication that the research has caused significant change or impact on opinions.

Abstract in brief

The study compared the effectiveness of extended-release viloxazine (VER) and atomoxetine in treating ADHD symptoms in both children and adults, with patients initially trying atomoxetine before switching to VER due to insurance requirements.
Patients' ADHD symptoms were measured using standardized scales before and after treatment, and both medications were adjusted based on FDA guidelines; the study aimed to see if switching to VER improved symptoms.
Results showed that, on average, patients experienced a significant improvement in ADHD symptoms after switching from atomoxetine to VER, suggesting VER may be an effective alternative for managing ADHD.

Read the full abstract

All mentions

Exploring Non-Stimulant Medications for ADHD Treatment Effectiveness

Explore ADHD treatment options beyond stimulants with Dr. Tracey Marks, focusing on nonstimulant medications like Qelbree that can enhance executive function and productivity in adults with ADHD.

Dr. Tracey Marks · Nov 15, 2023 1,087,868 views

Evaluating the Effectiveness and Side Effects of Strattera for ADHD

Main chapters include the history, comparison to alternatives, effects, side effects, and recent studies of Strattera in treating ADHD. The video reviews its efficacy, response times, and adverse effects, highlighting…

Dr. John Kruse · Sep 26, 2024 26,015 views

Lucas

@qfoiluks.bsky.social · Bluesky

Pelo amor de deus moça, vai estudar. Toma aqui um exemplo de onde começar: youtu.be/_p5ZeE7gc0I?...

Jul 10, 2025 · 2 shares View post →

Craig Diaman

@craigdiaman.bsky.social · Bluesky

I have found this resources very useful in more effectively advocating for myself youtu.be/_p5ZeE7gc0I?... us8.forward-to-friend.com/forward?u=05... youtu.be/-3LGjkboZ_8?...

Jan 7, 2025 · 1 share View post →